MetLife Investment Management LLC decreased its position in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 2.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,120 shares of the specialty chemicals company’s stock after selling 2,032 shares during the period. MetLife Investment Management LLC’s holdings in Sherwin-Williams were worth $26,763,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. CreativeOne Wealth LLC raised its position in Sherwin-Williams by 8.6% in the third quarter. CreativeOne Wealth LLC now owns 9,999 shares of the specialty chemicals company’s stock valued at $3,817,000 after purchasing an additional 790 shares during the period. Freedom Investment Management Inc. purchased a new stake in Sherwin-Williams in the 3rd quarter valued at about $234,000. Townsquare Capital LLC boosted its stake in Sherwin-Williams by 26.3% during the third quarter. Townsquare Capital LLC now owns 21,342 shares of the specialty chemicals company’s stock worth $8,145,000 after buying an additional 4,444 shares during the period. Cadence Bank increased its position in shares of Sherwin-Williams by 21.1% during the third quarter. Cadence Bank now owns 917 shares of the specialty chemicals company’s stock valued at $350,000 after acquiring an additional 160 shares during the last quarter. Finally, Avestar Capital LLC raised its position in Sherwin-Williams by 4.4% in the third quarter. Avestar Capital LLC now owns 1,747 shares of the specialty chemicals company’s stock valued at $667,000 after purchasing an additional 74 shares during the period. Hedge funds and other institutional investors own 77.67% of the company’s stock.
Analyst Ratings Changes
A number of analysts have issued reports on the stock. KeyCorp reiterated a “sector weight” rating on shares of Sherwin-Williams in a research note on Monday, October 7th. Wells Fargo & Company increased their price objective on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 15th. UBS Group reaffirmed an “underperform” rating on shares of Sherwin-Williams in a research report on Friday, October 18th. StockNews.com raised Sherwin-Williams from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Finally, Jefferies Financial Group lifted their price target on Sherwin-Williams from $392.00 to $415.00 and gave the stock a “buy” rating in a report on Monday, August 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $396.47.
Sherwin-Williams Price Performance
Shares of NYSE:SHW traded up $3.33 on Wednesday, hitting $399.47. The company had a trading volume of 502,305 shares, compared to its average volume of 1,640,606. The company has a current ratio of 0.83, a quick ratio of 0.51 and a debt-to-equity ratio of 1.97. The company has a market cap of $100.61 billion, a PE ratio of 39.46, a PEG ratio of 3.22 and a beta of 1.17. The Sherwin-Williams Company has a 52-week low of $272.34 and a 52-week high of $400.33. The business has a 50 day moving average of $377.90 and a 200 day moving average of $345.63.
Sherwin-Williams (NYSE:SHW – Get Free Report) last released its quarterly earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.56 by ($0.19). The firm had revenue of $6.16 billion for the quarter, compared to analyst estimates of $6.20 billion. Sherwin-Williams had a return on equity of 74.45% and a net margin of 11.09%. Sherwin-Williams’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the prior year, the business earned $3.20 earnings per share. As a group, equities analysts anticipate that The Sherwin-Williams Company will post 11.32 earnings per share for the current fiscal year.
Sherwin-Williams Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be given a $0.715 dividend. This represents a $2.86 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date is Friday, November 15th. Sherwin-Williams’s dividend payout ratio is currently 28.49%.
Insider Activity
In other news, CFO Allen J. Mistysyn sold 14,520 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the completion of the sale, the chief financial officer now directly owns 63,520 shares of the company’s stock, valued at $23,301,041.60. The trade was a 18.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Gregory P. Sofish sold 2,565 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $378.63, for a total value of $971,185.95. Following the completion of the transaction, the senior vice president now directly owns 6,329 shares in the company, valued at $2,396,349.27. This trade represents a 28.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.
Sherwin-Williams Profile
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
See Also
- Five stocks we like better than Sherwin-Williams
- How to Calculate Return on Investment (ROI)
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Short Selling: How to Short a Stock
- 2 Generic Drug Stocks Ready to Surge in 2025
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.